ADIPOQ and neoplasm: Adiponectin is mainly involved in the inhibition of tumor growth in nasopharyngeal [19], ovarian [20], hepatocellular [21], pancreatic [22], breast [23], colon [24], and prostate cancers [25] as well as in malignant mesotheliomas [26] and glioblastomas [27].